ZFYVE16 Activators
ZFYVE16, a protein involved in endosomal trafficking, is activated through various signaling pathways that influence its function. Activation of adenylate cyclase by specific compounds results in increased levels of intracellular cAMP, which in turn activates PKA, a kinase that can phosphorylate proteins, including those that interact with ZFYVE16. This modification can enhance ZFYVE16's binding affinity or influence its localization, which is critical for its role in endosome dynamics. Moreover, the activation of protein kinase C through DAG analogs can result in the phosphorylation of proteins within the endosomal signaling network, potentially leading to heightened activity of ZFYVE16. Similarly, compounds that elevate intracellular calcium can activate calcium-dependent kinases, further leading to the phosphorylation and consequent activation of ZFYVE16 or its associated proteins.
The PI3K/Akt signaling pathway, a crucial conduit for many cellular responses, is modulated by certain molecules that can lead to the phosphorylation of proteins engaging with ZFYVE16, thereby influencing its endosomal signaling role. Inhibition of specific phosphatases can prevent the dephosphorylation of proteins, thereby maintaining their activated state and indirectly enhancing the functional activity of ZFYVE16. Compounds that modulate the Wnt signaling pathway indirectly affect ZFYVE16's activity by altering endosomal trafficking. Moreover, inhibitors that target kinases involved in the MAPK/ERK pathway can also have implications for ZFYVE16's function. Activation of this pathway often leads to sequential phosphorylation events that can converge on the endosomal machinery, influencing the trafficking and sorting events in which ZFYVE16 is implicated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Diacylglycerol (DAG) analog that activates protein kinase C (PKC). PKC activation can phosphorylate proteins that interact with ZFYVE16, potentially enhancing its function in endosomal trafficking. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that increases intracellular calcium levels. Elevated calcium may activate calcium-dependent kinases, which could phosphorylate ZFYVE16 or its associated proteins, enhancing its activity in membrane trafficking. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates the PI3K/Akt signaling pathway, which can lead to the phosphorylation of proteins that interact with ZFYVE16, thereby potentially increasing its activity in endosomal signaling. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
cAMP analog that activates PKA. PKA activation can influence the phosphorylation state of ZFYVE16, which is important for its role in endosomal trafficking. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Serine/threonine phosphatase inhibitor that prevents dephosphorylation of proteins. This can lead to the sustained activation of proteins in pathways associated with ZFYVE16, indirectly increasing its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, leading to activation of Wnt signaling. This can result in changes in endosomal trafficking and potentially enhance the function of ZFYVE16 in this process. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Specific inhibitor of PKC that could lead to compensatory activation of related kinases, indirectly influencing the activity of ZFYVE16 in the endosomal signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that indirectly affects the activation state of downstream proteins that could interact with ZFYVE16, influencing its function in endosomal trafficking. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that prevents the activation of ERK/MAPK pathway. This could lead to compensatory regulatory mechanisms that indirectly activate ZFYVE16 or its interactors in endosomal dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can alter autophagy and endosomal trafficking. Such alterations can modify the functional state of ZFYVE16, as it is involved in these cellular processes. | ||||||